Magnetic resonance imaging (MRI) and dynamic MRI evaluation of extranodal non-hodgkin lymphoma in the oral and maxillofacial regions. A systematic review.

Authors

  • Dr. Sebastin Varghese Paul Associate Professor, Department of Radiology, Dr. SMCSI Medical College and Research Institute, Karakonam, Thiruvananthapuram District, Kerala, India
  • Dr. Dharanidharan G. D Mediscan Systems, No. 197, Dr. Natesan Road, Mylapore, Chennai 600004, Tamil Nadu, India
  • Dr. Karthik Shunmugavelu Assistant Professor, Department of Dentistry, PSP Medical College Hospital and Research Institute, Tambaram–Kanchipuram Main Road, Oragadam, Panruti, Kanchipuram District, Tamil Nadu 631604, India

DOI:

https://doi.org/10.51168/sjhrafrica.v7i3.2476

Keywords:

Apparent diffusion coefficient, Diagnostic imaging, Diffusion-weighted imaging, Dynamic contrast-enhanced MRI, Extranodal non-Hodgkin lymphoma, Head and neck malignancies, Magnetic resonance imaging, Oral and maxillofacial region

Abstract

Background:
Extranodal non-Hodgkin lymphoma (NHL) in the oral and maxillofacial region often mimics squamous cell carcinoma (SCC), complicating diagnosis. Magnetic resonance imaging (MRI) and dynamic contrast-enhanced MRI (DCE-MRI) offer detailed soft-tissue and functional assessment. This review evaluated their role in identifying characteristic imaging features of extranodal NHL.

Methods:
Conducted per PRISMA 2020 and registered in PROSPERO (CRD420251178334), a comprehensive search of PubMed, Scopus, Web of Science, and Google Scholar (up to 2025) was performed. Studies on histopathologically confirmed extranodal NHL assessed using MRI or DCE-MRI were included. Data on imaging features, apparent diffusion coefficient (ADC), enhancement kinetics, and diagnostic performance were extracted. Study quality was evaluated using QUADAS-2, and findings were synthesized qualitatively.

Results:
Seven studies (2004–2018) involving ~250 patients were included. NHL typically showed intermediate-to-low T1 and intermediate-to-high T2 signal intensity, homogeneous contrast enhancement, and submucosal spread with preserved mucosa. DCE-MRI demonstrated a Type II (plateau) enhancement curve, while diffusion-weighted imaging revealed low ADC values (0.68–0.90 × 10⁻³ mm²/s), consistent with high cellularity. SCC showed heterogeneous enhancement, necrosis, and higher ADC values. Combined DWI and DCE-MRI achieved diagnostic accuracies >90%, with sensitivities of 92–96% and specificities of 88–93%.

Conclusion:
Extranodal NHL exhibits consistent MRI characteristics correlating with histopathology. Multiparametric MRI aids pre-biopsy differentiation from carcinoma and supports treatment planning. Standardized imaging protocols and validated ADC thresholds are needed to improve diagnostic precision.

Author Biographies

Dr. Sebastin Varghese Paul, Associate Professor, Department of Radiology, Dr. SMCSI Medical College and Research Institute, Karakonam, Thiruvananthapuram District, Kerala, India

is an Associate Professor of Radiology with expertise in cross-sectional imaging and head and neck radiologic diagnostics. His academic work includes advanced MRI applications in oncologic imaging.

Dr. Dharanidharan G. D, Mediscan Systems, No. 197, Dr. Natesan Road, Mylapore, Chennai 600004, Tamil Nadu, India

is a clinician in private practice with an interest in diagnostic imaging and maxillofacial pathology, focusing on radiologic–pathologic correlation in head and neck diseases.

Dr. Karthik Shunmugavelu, Assistant Professor, Department of Dentistry, PSP Medical College Hospital and Research Institute, Tambaram–Kanchipuram Main Road, Oragadam, Panruti, Kanchipuram District, Tamil Nadu 631604, India

is an academic oral and maxillofacial pathologist with advanced training in oral medicine, diagnostic pathology and research methodology. His research interests include head and neck oncology, imaging correlation and translational diagnostic sciences.

References

Sapkota S, Shaikh H. Non-Hodgkin Lymphoma. [Updated 2023 Feb 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559328/

Vannata B, Zucca E. Primary extranodal B-cell lymphoma: current concepts and treatment strategies. Chin Clin Oncol. 2015 Mar;4(1):10. doi: 10.3978/j.issn.2304-3865.2014.12.01. PMID: 25841717.

Reginelli A, Urraro F, Sangiovanni A, Russo GM, Russo C, Grassi R, Agostini A, Belfiore MP, Cellina M, Floridi C, Giovagnoni A, Sica A, Cappabianca S. Extranodal Lymphomas: a pictorial review for CT and MRI classification. Acta Biomed. 2020 Jul 13;91(8-S):34-42. doi: 10.23750/abm.v91i8-S.9971. PMID: 32945277; PMCID: PMC7944666.

Triantafillidou, Katherine & Dimitrakopoulos, John & Iordanidis, Fotis & Gkagkalis, Asterios. (2012). Extranodal Non-Hodgkin Lymphomas of the Oral Cavity and Maxillofacial Region: A Clinical Study of 58 Cases and Review of the Literature. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons. 70. 10.1016/j.joms.2012.01.018.

Höglund Wetter M, Mattsson U. Oral manifestations of extranodal lymphomas - a review of the literature with emphasis on clinical implications for the practicing dentist. Acta Odontol Scand. 2022 Aug;80(6):401-410. doi: 10.1080/00016357.2021.2020896. Epub 2022 Feb 2. PMID: 35108151.

Antonio Cortese, Giuseppe Pantaleo, IdaLucia Ferrara, Alessandro Vatrella, Immmacolata Cozzolino, Vincenzo Di Crescenzo, Massimo Amato, Bone and soft tissue non-Hodgkin lymphoma of the maxillofacial area: Report of two cases, literature review and new therapeutic strategies, International Journal of Surgery, Volume 12, Supplement 2, 2014, Pages S23-S28, ISSN 1743-9191, https://doi.org/10.1016/j.ijsu.2014.08.388.

Henry Y Dong, Nancy L Harris, Frederic I Preffer, Martha B Pitman, Fine-Needle Aspiration Biopsy in the Diagnosis and Classification of Primary and Recurrent Lymphoma: A Retrospective Analysis of the Utility of Cytomorphology and Flow Cytometry, Modern Pathology, Volume 14, Issue 5, 2001, Pages 472-481, ISSN 0893-3952, https://doi.org/10.1038/modpathol.3880336

Öcbe M. The evolving role of MRI in dentomaxillofacial diagnostics: a comprehensive review. Eur Oral Res. 2025 Jan 5;59(1):58-67. doi: 10.26650/eor.2024145664. PMID: 40453404; PMCID: PMC12126162.

Chang AE, Matory YL, Dwyer AJ, Hill SC, Girton ME, Steinberg SM, Knop RH, Frank JA, Hyams D, Doppman JL, et al. Magnetic resonance imaging versus computed tomography in the evaluation of soft tissue tumors of the extremities. Ann Surg. 1987 Apr;205(4):340-8. doi: 10.1097/00000658-198704000-00002. PMID: 3032120; PMCID: PMC1492735.

Chua SC, Rozalli FI, O'Connor SR. Imaging features of primary extranodal lymphomas. Clin Radiol. 2009 Jun;64(6):574-88. doi: 10.1016/j.crad.2008.11.001. Epub 2008 Dec 23. PMID: 19414080.

Breuninger H, Schaumburg-Lever G, Holzschuh J, Horny HP. Desmoplastic squamous cell carcinoma of skin and vermilion surface: a highly malignant subtype of skin cancer. Cancer. 1997 Mar 1;79(5):915-9. doi: 10.1002/(sici)1097-0142(19970301)79:5<915::aid-cncr7>3.0.co;2-a. PMID: 9041153.

Zheng N, Li R, Liu W, Shao S, Jiang S. The diagnostic value of combining conventional, diffusion-weighted imaging and dynamic contrast-enhanced MRI for salivary gland tumors. Br J Radiol. 2018 Sep;91(1089):20170707. doi: 10.1259/bjr.20170707. Epub 2018 Jun 27. PMID: 29902075; PMCID: PMC6223171.

Yang X, Dong M, Li S, Chai R, Zhang Z, Li N, Zhang L. Diffusion-weighted imaging or dynamic contrast-enhanced curve: a retrospective analysis of contrast-enhanced magnetic resonance imaging-based differential diagnoses of benign and malignant breast lesions. Eur Radiol. 2020 Sep;30(9):4795-4805. doi: 10.1007/s00330-020-06883-w. Epub 2020 Apr 29. PMID: 32350660.

White NS, McDonald C, Farid N, Kuperman J, Karow D, Schenker-Ahmed NM, Bartsch H, Rakow-Penner R, Holland D, Shabaik A, Bjørnerud A, Hope T, Hattangadi-Gluth J, Liss M, Parsons JK, Chen CC, Raman S, Margolis D, Reiter RE, Marks L, Kesari S, Mundt AJ, Kane CJ, Carter BS, Bradley WG, Dale AM. Diffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imaging. Cancer Res. 2014 Sep 1;74(17):4638-52. doi: 10.1158/0008-5472.CAN-13-3534. Erratum in: Cancer Res. 2014 Nov 15;74(22):6733. McDonald, Carrie R [corrected to McDonald, Carrie];Kaine, Christopher J [corrected to Kane, Christopher J]. PMID: 25183788; PMCID: PMC4155409.

Ichikawa Y, Sumi M, Sasaki M, Sumi T, Nakamura T. Efficacy of diffusion-weighted imaging for the differentiation between lymphomas and carcinomas of the nasopharynx and oropharynx: correlations of apparent diffusion coefficients and histologic features. AJNR Am J Neuroradiol. 2012 Apr;33(4):761-6. doi: 10.3174/ajnr.A2834. Epub 2011 Dec 15. PMID: 22173765; PMCID: PMC8050466.

Gordon Y, Partovi S, Müller-Eschner M, Amarteifio E, Bäuerle T, Weber MA, Kauczor HU, Rengier F. Dynamic contrast-enhanced magnetic resonance imaging: fundamentals and application to the evaluation of the peripheral perfusion. Cardiovasc Diagn Ther. 2014 Apr;4(2):147-64. doi: 10.3978/j.issn.2223-3652.2014.03.01. PMID: 24834412; PMCID: PMC3996240.

Chayakulkheeree J, Tongin K, Boonjunwetwat D. Volumetric kinetic assessment in dynamic contrast enhanced-MRI (DCE-MRI) of breast cancer: A new method for evaluation of whole tumor enhancing pattern. Chula Med J [internet]. 2020 Jan. 1 [cited 2025 Oct. 30];64(1). available from: https://he05.tci-thaijo.org/index.php/CMJ/article/view/177

Surov A, Meyer HJ, Gawlitza M, Höhn AK, Boehm A, Kahn T, Stumpp P. Correlations Between DCE MRI and Histopathological Parameters in Head and Neck Squamous Cell Carcinoma. Transl Oncol. 2017 Feb;10(1):17-21. doi: 10.1016/j.tranon.2016.10.001. Epub 2016 Nov 24. PMID: 27888709; PMCID: PMC5124350.

Yu, L., Yu, S., Wang, F. et al. Multiparametric MRI for differential diagnosis of primary central nervous system lymphoma and atypical glioblastoma: an analysis incorporating DWI, DCE-MRI and contrast agent preload DSC-PWI. BMC Med Imaging 25, 345 (2025). https://doi.org/10.1186/s12880-025-01886-9

Nascimento D, Suchard G, Hatem M, de Abreu A. The role of magnetic resonance imaging in the evaluation of bone tumours and tumour-like lesions. Insights Imaging. 2014 Aug;5(4):419-40. doi: 10.1007/s13244-014-0339-z. Epub 2014 Jul 9. PMID: 25005774; PMCID: PMC4141345.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71. PMID: 33782057; PMCID: PMC8005924.

Harbishettar, Vijaykumar. The Updated PROSPERO for Systematic Reviews. Journal of Psychiatry Spectrum 4(2):p 129-130, Apr–Jun 2025. | DOI: 10.4103/jopsys.jopsys_32_25

Amir-Behghadami M, Janati A Population, Intervention, Comparison, Outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews Emergency Medicine Journal 2020;37:387.

Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM; QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011 Oct 18;155(8):529-36. doi: 10.7326/0003-4819-155-8-201110180-00009. PMID: 22007046.

Asaumi J, Yanagi Y, Konouchi H, Hisatomi M, Matsuzaki H, Kishi K. Application of dynamic contrast-enhanced MRI to differentiate malignant lymphoma from squamous cell carcinoma in the head and neck. Oral Oncol. 2004 Jul;40(6):579-84. doi: 10.1016/j.oraloncology.2003.12.002. PMID: 15063385.

Maeda M, Kato H, Sakuma H, Maier SE, Takeda K. Usefulness of the apparent diffusion coefficient in line scan diffusion-weighted imaging for distinguishing between squamous cell carcinomas and malignant lymphomas of the head and neck. AJNR Am J Neuroradiol. 2005 May;26(5):1186-92. PMID: 15891182; PMCID: PMC8158607.

Matsuzaki H, Hara M, Yanagi Y, Asaumi J, Katase N, Unetsubo T, Hisatomi M, Konouchi H, Takenobu T, Nagatsuka H. Magnetic resonance imaging (MRI) and dynamic MRI evaluation of extranodal non-Hodgkin lymphoma in oral and maxillofacial regions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Jan;113(1):126-33. doi: 10.1016/j.tripleo.2011.07.038. Epub 2012 Feb 3. PMID: 22669071.

Kato H, Kanematsu M, Kawaguchi S, Watanabe H, Mizuta K, Aoki M. Evaluation of imaging findings differentiating extranodal non-Hodgkin's lymphoma from squamous cell carcinoma in naso- and oropharynx. Clin Imaging. 2013 Jul-Aug;37(4):657-63. doi: 10.1016/j.clinimag.2012.11.007. Epub 2013 Jan 14. PMID: 23332292.

Kato H, Kanematsu M, Watanabe H, Kawaguchi S, Mizuta K, Aoki M. Differentiation of extranodal non-Hodgkins lymphoma from squamous cell carcinoma of the maxillary sinus: a multimodality imaging approach. Springerplus. 2015 May 15;4:228. doi: 10.1186/s40064-015-0974-y. PMID: 26120502; PMCID: PMC4478190.

Park M, Kim J, Choi YS, Lee SK, Koh YW, Kim SH, Choi EC. Application of Dynamic Contrast-Enhanced MRI Parameters for Differentiating Squamous Cell Carcinoma and Malignant Lymphoma of the Oropharynx. AJR Am J Roentgenol. 2016 Feb;206(2):401-7. doi: 10.2214/AJR.15.14550. PMID: 26797371.

Kim SH, Mun SJ, Kim HJ, Kim SL, Kim SD, Cho KS. Differential Diagnosis of Sinonasal Lymphoma and Squamous Cell Carcinoma on CT, MRI and PET/CT. Otolaryngol Head Neck Surg. 2018 Sep;159(3):494-500. doi: 10.1177/0194599818770621. Epub 2018 Apr 17. PMID: 29661053.

Downloads

Published

2025-03-01

How to Cite

Paul, S. V., G. D, D. D. ., & Shunmugavelu, K. . (2025). Magnetic resonance imaging (MRI) and dynamic MRI evaluation of extranodal non-hodgkin lymphoma in the oral and maxillofacial regions. A systematic review. Student’s Journal of Health Research Africa, 7(3), 15. https://doi.org/10.51168/sjhrafrica.v7i3.2476

Issue

Section

Section of Radiology and Radiotherapy